Comparison of PSMA-PET/CT, choline-PET/CT, NaF-PET/CT, MRI, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a …
J Zhou, Z Gou, R Wu, Y Yuan, G Yu, Y Zhao - Skeletal radiology, 2019 - Springer
Objective A systematic review and meta-analysis to compare the diagnostic performance of
prostate-specific membrane antigen (PSMA)-PET/CT, choline-PET/CT, Sodium Fluoride …
prostate-specific membrane antigen (PSMA)-PET/CT, choline-PET/CT, Sodium Fluoride …
Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer
Glutamate carboxypeptidase II (GCPII) is a membrane-bound binuclear zinc
metallopeptidase with the highest expression levels found in the nervous and prostatic …
metallopeptidase with the highest expression levels found in the nervous and prostatic …
Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, 18F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone …
Purpose. Detection of bone metastases in breast and prostate cancer patients remains a
major clinical challenge. The aim of the current trial was to compare the diagnostic accuracy …
major clinical challenge. The aim of the current trial was to compare the diagnostic accuracy …
18F-Sodium Fluoride PET as a Diagnostic Modality for Metabolic, Autoimmune, and Osteogenic Bone Disorders: Cellular Mechanisms and Clinical Applications
In a healthy body, homeostatic actions of osteoclasts and osteoblasts maintain the integrity
of the skeletal system. When cellular activities of osteoclasts and osteoblasts become …
of the skeletal system. When cellular activities of osteoclasts and osteoblasts become …
18F-NaF PET/CT: EANM procedure guidelines for bone imaging
M Beheshti, FM Mottaghy, F Payche… - European journal of …, 2015 - Springer
The aim of this guideline is to provide minimum standards for the performance and
interpretation of 18 F-NaF PET/CT scans. Standard acquisition and interpretation of nuclear …
interpretation of 18 F-NaF PET/CT scans. Standard acquisition and interpretation of nuclear …
Therapy monitoring of skeletal metastases with whole‐body diffusion MRI
AR Padhani, A Makris, P Gall, DJ Collins… - Journal of Magnetic …, 2014 - Wiley Online Library
Current methods of assessing tumor response at skeletal sites with metastatic disease use a
combination of imaging tests, serum and urine biochemical markers, and symptoms …
combination of imaging tests, serum and urine biochemical markers, and symptoms …
Prospective comparison of 99mTc-MDP scintigraphy, combined 18F-NaF and 18F-FDG PET/CT, and whole-body MRI in patients with breast and prostate cancer
We prospectively evaluated the use of combined 18F-NaF/18F-FDG PET/CT in patients with
breast and prostate cancer and compared the results with those for 99mTc-MDP bone …
breast and prostate cancer and compared the results with those for 99mTc-MDP bone …
Sodium 18F-fluoride PET/CT of bone, joint, and other disorders
The use of 18 F-sodium fluoride (18 F-NaF) with PET/CT is increasing. This resurgence of an
old tracer has been fueled by several factors including superior diagnostic performance over …
old tracer has been fueled by several factors including superior diagnostic performance over …
Prospective evaluation of 18F-NaF and 18F-FDG PET/CT in detection of occult metastatic disease in biochemical recurrence of prostate cancer
Purpose This study aimed to perform a prospective evaluation of 18 F-NaF and 18 F-FDG
PET/CT in the detection of occult metastatic disease in men with prostate cancer and …
PET/CT in the detection of occult metastatic disease in men with prostate cancer and …
PSMA PET and radionuclide therapy in prostate cancer
Prostate cancer (PCa) is the most common malignancy in men and a major cause of cancer
death. Accurate imaging plays an important role in diagnosis, staging, restaging, detection of …
death. Accurate imaging plays an important role in diagnosis, staging, restaging, detection of …